The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
List of Current Studies seeking participants

dianetavegia
CSN Member Posts: 1,942 Member
Someone took the time to find these on another forum and I thought we might have a member needing this info!
Gemzar info
MEK/PI3K inhibitors:
biologic IGF receptor targets
Advanced, Refractory Solid Tumors
This study is currently recruiting participants.
FOLFIRI in Combination With AMG 479 or AMG 655 vs FOLFIRI in KRAS-mutant Metastatic Colorectal Carcinoma
This study is currently recruiting participants.
Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer
This study is currently recruiting participants.
Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)
This study is currently recruiting participants.
Torisel Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer
Irinotecan + Cetuximab +/- RAD001
Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
Designer T Cells
AMG 386 in Combination With FOLFIRI
Tivozanib (AV-951) Plus FOLFOX6
ABT-888 in Combination With Temozolomide
FOLFIRI Plus Cetuximab Plus IMO-2055
Gemzar info
MEK/PI3K inhibitors:
biologic IGF receptor targets
Advanced, Refractory Solid Tumors
This study is currently recruiting participants.
FOLFIRI in Combination With AMG 479 or AMG 655 vs FOLFIRI in KRAS-mutant Metastatic Colorectal Carcinoma
This study is currently recruiting participants.
Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer
This study is currently recruiting participants.
Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)
This study is currently recruiting participants.
Torisel Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer
Irinotecan + Cetuximab +/- RAD001
Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
Designer T Cells
AMG 386 in Combination With FOLFIRI
Tivozanib (AV-951) Plus FOLFOX6
ABT-888 in Combination With Temozolomide
FOLFIRI Plus Cetuximab Plus IMO-2055
Comments
-
Cool!
Wow- thank you so very much for posting these links, Diane!
I quickly clicked on the first link "Gemzar info" & read that the locations for this trial are in No. Carolina, Massachussetts, and I just forgot the other, but on the east coast. I also just found another called a phase1b/2 study of ARRY-334543 and Gemcitabine in patients with advanced solid tumors. The clinicaltrials.gov identifier # is NCT00862524. I noted that it has a location in Santa Monica, CA which would be about 2 hrs from me.
I will look into all the other links when I get home later tonight.
This site is so great how we can share information and help others!
Lisa -
-
Brooks, I heard they went up in smokejust4Brooks said:No
Medical marijuana Studies?
Life is funny sometimes
Brooks
Ventilator Blues?.....steve -
-
-
-
Discussion Boards
- All Discussion Boards
- 6 Cancer Survivors Network Information
- 6 Welcome to CSN
- 122.5K Cancer specific
- 2.8K Anal Cancer
- 456 Bladder Cancer
- 312 Bone Cancers
- 1.7K Brain Cancer
- 28.6K Breast Cancer
- 408 Childhood Cancers
- 28K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13.1K Head and Neck Cancer
- 6.4K Kidney Cancer
- 681 Leukemia
- 803 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 242 Multiple Myeloma
- 7.2K Ovarian Cancer
- 69 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 743 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.4K Lifestyle Discussion Boards